VIAD PHARMA ApS: Financial statements 2018
CVR: 36433892
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
VIAD PHARMA ApS (CVR 36433892) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,371,505 and a net result of DKK 552,786 compared with DKK 676,743 the year before. That is a decrease of 10.8% compared with the year before. Equity in the 2018 report amounted to DKK 713,727. The solvency ratio was 45.8%.
- Gross Profit
- DKK 1,371,505
- Profit/Loss
- DKK 552,786
- Equity
- DKK 713,727
- Total Assets
- DKK 1,558,866
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 1.4 mio. | 553 t. | 714 t. | - |
| 2017 | - | 1.5 mio. | 677 t. | 761 t. | - |
| 2016 | - | 1.4 mio. | 623 t. | 684 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
VIAD PHARMA ApS has published its annual report for 2017. Gross profit came to DKK 1,537,937, and the net result was DKK 676,743.
About VIAD PHARMA ApS
VIAD PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Heidi Meier. The company is owned by HEIDI MEIER HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,031,002 and a net result of DKK 168,032 compared with DKK 808,813 the year before. Equity in the 2025 report amounted to DKK 236,399.